The largest database of trusted experimental protocols

2 protocols using pegfr1173

1

Quantitative Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For WB, Samples were loaded onto 10% SDS-polyacrylamide gels, transferred to polyvinylidene difluoride membranes (Millipore Corp, Bedford, MA, USA) and incubated with primary CRT, pEGFR1173, pEGFR-Tyr1068 (pEGFR1068) (Abcam), pEGFR-Tyr845 (pEGFR845) (Abcam), Fibronectin, Integrinβ1, Integrinα5 (Abcam), c-Myc (Cell Signaling Technology, Danvers, MA, USA), pERK (Cell Signaling Technology), Caveolin-1 (Proteintech), E-cad, N-cadherin (N-cad, Abcam), Vimentin (Proteintech), MMP9 (Proteintech), ZO-1 (Proteintech), β-catenin (Proteintech), GATA3 (Proteintech), alpha smooth muscle actin (a-SMA, Abcam) and GAPDH (Proteintech) antibodies overnight at 4 °C. Membranes were incubated with horseradish peroxidase-conjugated monoclonal secondary antibody (Santa Cruz, CA, UK) at room temperature for 1.5 h, respectively. Immunoreactive protein bands were visualized with an ECL Detection Kit (Thermo scientific, Rockford, IL, USA). Each experiment was repeated three times.
+ Open protocol
+ Expand
2

EGFR Signaling Pathway Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The growth factor EGF was from Life Technologies (Carlsbad, CA). Antibodies were as follows: EGFR (555996; BD Biosciences, San Jose, CA), paxillin (610052; BD Biosciences), ppaxillin Y118 (44-722G; Life Technologies), and pEGFR1173 (Abcam, Cambridge, MA). Drugs were erlotinib (LC Labs, Woburn, MA), gefitinib (Peprotech, Rocky Hill, NJ), Cilengitide (Selleck Chemicals, Houston, TX), P1D6 α5 blocking antibody (DSHB, Iowa City, IA), and PTP1Bi (Millipore, Burlington, MA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!